Rinaldo Bellomo

Rinaldo Bellomo

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Rinaldo Bellomo

Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2004 in Critical Care
Verified
Journal Article
Open access
PDF file
RBRinaldo Bellomo
Rinaldo Bellomo
CRClaudio Ronco
Claudio Ronco
JKJohn A Kellum
John A Kellum
RMRavindra L Mehta
Ravindra L Mehta
PPPaul Palevsky
Paul Palevsky
TWThe Adqi Workgroup
The Adqi Workgroup
Introduction: There is no consensus definition of acute renal failure (ARF) in critically ill patients. More than 30 different definitions have been used in the literature, creating much confusion and making comparisons difficult. Similarly, strong debate exists on the validity and clinical relevance of animal models of ARF; on choices of fluid management and of end-points for trials of new interventions in this field; and on how information technology can be used to assist this process. Accordingly, we sought to review the available evidence, make recommendations and delineate key questions for future studies. Methods: We undertook a systematic review of the literature using Medline and PubMed searches. We determined a list of key questions and convened a 2-day consensus conference to develop summary statements via a series of alternating breakout and plenary sessions. In these sessions, we identified supporting evidence and generated recommendations and/or directions for future research. Results: We found sufficient consensus on 47 questions to allow the development of recommendations. Importantly, we were able to develop a consensus definition for ARF. In some cases it was also possible to issue useful consensus recommendations for future investigations. We present a summary of the findings. (Full versions of the six workgroups' findings are available on the internet at http://www.ADQI.net) Conclusion: Despite limited data, broad areas of consensus exist for the physiological and clinical principles needed to guide the development of consensus recommendations for defining ARF, selection of animal models, methods of monitoring fluid therapy, choice of physiological and clinical end-points for trials, and the possible role of information technology.

17 August 2005 in JAMA
Verified
Journal Article
Open access
PDF file
SUShigehiko Uchino
Shigehiko Uchino
JKJohn A Kellum
John A Kellum
RBRinaldo Bellomo
Rinaldo Bellomo
GDGordon S. Doig
Gordon S. Doig
HMHiroshi Morimatsu
Hiroshi Morimatsu
FBFor The Beginning
For The Beginning
The epidemiology and outcome of acute renal failure (ARF) in critically ill patients in different regions of the world are not well understood. Although there have been several epidemiological studies of ARF,1-16 most are either single center1-3,6-8,12 or if multicenter are confined to a single country.4,5,9-11,13,15,16 The period prevalence and hospital mortality reported in these studies have varied widely (single-center studies: 1%-25%; multicenter studies: 39%-71%) and most studies are not comparable because they used different inclusion criteria. In 1 multinational study14 that collected data for a general severity scoring system and provided further but limited and indirect information about the epidemiology of ARF, more than 90% of participating centers were in Europe or North America. All studies of ARF have been conducted in Australia, Europe, or North America.

11 July 2015 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
EHEric Hoste
Eric Hoste
SBSean M. Bagshaw
Sean M. Bagshaw
RBRinaldo Bellomo
Rinaldo Bellomo
CCCynthia M. Cely
Cynthia M. Cely
RCRoos Colman
Roos Colman
JKJohn A. Kellum
John A. Kellum

1 November 2008 in JACC
Verified
Journal Article
Closed access
CRClaudio Ronco
Claudio Ronco
MHMikko Haapio
Mikko Haapio
AHAndrew A. House
Andrew A. House
NANagesh Anavekar
Nagesh Anavekar
RBRinaldo Bellomo
Rinaldo Bellomo

2 April 2014 in JAMA
Verified
Journal Article
Closed access
PDF file
KKKirsi-Maija Kaukonen
Kirsi-Maija Kaukonen
MBMichael Bailey
Michael Bailey
SSSatoshi Suzuki
Satoshi Suzuki
DPDavid Pilcher
David Pilcher
RBRinaldo Bellomo
Rinaldo Bellomo
Research from JAMA — Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012

27 February 2017 in Nature Reviews Nephrology
Verified
Journal Article
Open access
PDF file
LCLakhmir S. Chawla
Lakhmir S. Chawla
RBRinaldo Bellomo
Rinaldo Bellomo
Azra BihoracAzra Bihorac
Azra Bihorac
SGStuart L. Goldstein
Stuart L. Goldstein
ESEdward D. Siew
Edward D. Siew
JKJohn A. Kellum
John A. Kellum
Consensus definitions have been reached for both acute kidney injury (AKI) and chronic kidney disease (CKD) and these definitions are now routinely used in research and clinical practice. The KDIGO guideline defines AKI as an abrupt decrease in kidney function occurring over 7 days or less, whereas CKD is defined by the persistence of kidney disease for a period of >90 days. AKI and CKD are increasingly recognized as related entities and in some instances probably represent a continuum of the disease process. For patients in whom pathophysiologic processes are ongoing, the term acute kidney disease (AKD) has been proposed to define the course of disease after AKI; however, definitions of AKD and strategies for the management of patients with AKD are not currently available. In this consensus statement, the Acute Disease Quality Initiative (ADQI) proposes definitions, staging criteria for AKD, and strategies for the management of affected patients. We also make recommendations for areas of future research, which aim to improve understanding of the underlying processes and improve outcomes for patients with AKD.